ArticleBreast cancer research : BCR2019

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.

Suryavathi Viswanadhapalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.